- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-20
DOI
10.1007/s40257-018-0370-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials
- (2018) Patrick Fleming et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy
- (2018) Lieneke F.M. Ariëns et al. Therapeutic Advances in Chronic Disease
- Dupilumab in the treatment of moderate-to-severe atopic dermatitis
- (2017) Magdalena Kraft et al. Expert Review of Clinical Immunology
- Therapeutic pipeline for atopic dermatitis: End of the drought?
- (2017) Amy S. Paller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey
- (2017) Laurent Eckert et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
- (2017) Mark Boguniewicz et al. Journal of Allergy and Clinical Immunology-In Practice
- Targeting the T Helper 2 Inflammatory Axis in Atopic Dermatitis
- (2016) Adriana S. Moreno et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- 373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance
- (2016) E. Guttman-Yassky et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- 372 The effect of dupilumab on biomarkers in a randomized phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis
- (2016) J. Hamilton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults
- (2016) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug evaluation review: dupilumab in atopic dermatitis
- (2015) Jennifer D Hamilton et al. Immunotherapy
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers
- (2013) Allen Radin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now